Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) EBT (2019 - 2023)

Historic EBT for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to -$45.4 million.

  • ADC Therapeutics' EBT rose 1152.98% to -$45.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$157.8 million, marking a year-over-year decrease of 1730.71%. This contributed to the annual value of -$154661.0 for FY2022, which is 3850.58% up from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' EBT is -$45.4 million, which was up 1152.98% from -$52.7 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' EBT ranged from a high of -$20190.0 in Q4 2022 and a low of -$126.5 million during Q2 2020
  • Over the past 5 years, ADC Therapeutics' median EBT value was -$45.4 million (recorded in 2023), while the average stood at -$39.9 million.
  • As far as peak fluctuations go, ADC Therapeutics' EBT crashed by 54369031.56% in 2020, and later skyrocketed by 6532.28% in 2022.
  • Quarter analysis of 5 years shows ADC Therapeutics' EBT stood at -$35170.0 in 2019, then tumbled by 57707.79% to -$20.3 million in 2020, then surged by 99.72% to -$56352.0 in 2021, then skyrocketed by 64.17% to -$20190.0 in 2022, then crashed by 224773.7% to -$45.4 million in 2023.
  • Its EBT was -$45.4 million in Q3 2023, compared to -$52.7 million in Q2 2023 and -$59.7 million in Q1 2023.